Public Health Action Plan to Combat Antimicrobial Resistance
Overview of the Action Plan
Rationale for Action Plan
The Action Plan is a blueprint for specific, coordinated, federal actions to address the growing threat of antimicrobial resistance in the United States. In the Action Plan, the Interagency Task Force on Antimicrobial Resistance (ITFAR) addresses the three areas of federal action: surveillance, prevention and control; research; and regulatory pathways for new products. The Action Plan outlines goals and actions that the participating federal agencies and departments are pursuing or planning to pursue in an effort to respond to the complex public health risk posed by antimicrobial resistance.
Following each of the goals listed for each focus area are several action items that define topic areas for specific projects or implementation steps. Wherever possible, action items are populated with specific projects or implementation steps to provide greater specificity for planned federal activities. The action items, projects and implementation steps do not represent an exhaustive list of activities. Project lists will be updated annually, and actions will be updated every two years.
Focus Area I: Surveillance, Prevention and Control of Antimicrobial Resistant Infections
Overarching Goal: In order to develop and implement effective control strategies there must be 1) continuous or periodic monitoring of infections caused by antimicrobial resistant (AR) microorganisms, 2) comprehensive knowledge of the use of antimicrobial agents across all sectors and 3) the capacity to develop, evaluate and implement effective prevention and containment strategies nationally and globally.
Focus Area II: Research
Overarching Goal: Encourage, conduct and support basic and translational research to enhance our understanding of factors leading to the development of AR microorganisms, their transmission in various settings and optimal modes of prevention, diagnosis and therapy.
Focus Area III: Regulatory Pathways for New Products
Overarching Goal: Encourage the development of products for bacterial disease to improve our capacity to diagnose, prevent and treat infections, including infections caused by resistant microorganisms.
|Acronyms and Abbreviations|
|AHRQ||Agency for Healthcare Research and Quality|
|APHL||Association of Public Health Laboratories|
|ASH||Office of the Assistant Secretary for Health (HHS)|
|ASPE||Office of the Assistant Secretary for Planning and Evaluation|
|ASPR||Office of the Assistant Secretary for Preparedness and Response|
|BARDA||Biomedical Advanced Research Development Authority (HHS)|
|CDC||Centers for Disease Control and Prevention|
|CLSI||Clinical and Laboratory Standards Institute|
|CMS||Centers for Medicare and Medicaid Services|
|CSTE||Council of State and Territorial Epidemiologists|
|DoD||Department of Defense|
|EPA||Environmental Protection Agency|
|FDA||Food and Drug Administration|
|HHS||Department of Health and Human Services|
|HRSA||Health Resources and Services Administration|
|IPEC||Inpatient Evaluation Center|
|MRSA||Methicillin-resistant Staphylococcus aureus|
|NHSN||National Healthcare Safety Network|
|NIH||National Institutes of Health|
|USDA||United States Department of Agriculture|
|VA||Department of Veterans Affairs|
|VHA||Veterans Health Administration|
|XDR TB||Extensively drug-resistant tuberculosis|